664 related articles for article (PubMed ID: 31696664)
1. Nanotechnology platforms for cancer immunotherapy.
Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
[TBL] [Abstract][Full Text] [Related]
2. Targeting the innate immune system with nanoparticles for cancer immunotherapy.
Li K; Zhang Z; Mei Y; Li M; Yang Q; Wu Q; Yang H; He L; Liu S
J Mater Chem B; 2022 Mar; 10(11):1709-1733. PubMed ID: 35179545
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in applying nanotechnologies for cancer immunotherapy.
Mahjub R; Jatana S; Lee SE; Qin Z; Pauli G; Soleimani M; Madadi S; Li SD
J Control Release; 2018 Oct; 288():239-263. PubMed ID: 30223043
[TBL] [Abstract][Full Text] [Related]
4. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
Aikins ME; Xu C; Moon JJ
Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
Liu J; Zhang R; Xu ZP
Small; 2019 Aug; 15(32):e1900262. PubMed ID: 30908864
[TBL] [Abstract][Full Text] [Related]
6. Regulation of cancer-immunity cycle and tumor microenvironment by nanobiomaterials to enhance tumor immunotherapy.
Yang J; Zhang C
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Jul; 12(4):e1612. PubMed ID: 32114718
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnology in the arena of cancer immunotherapy.
Asadujjaman M; Cho KH; Jang DJ; Kim JE; Jee JP
Arch Pharm Res; 2020 Jan; 43(1):58-79. PubMed ID: 31956965
[TBL] [Abstract][Full Text] [Related]
8. Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.
Li W; Wei H; Li H; Gao J; Feng SS; Guo Y
Nanomedicine (Lond); 2014 Nov; 9(16):2587-605. PubMed ID: 25490427
[TBL] [Abstract][Full Text] [Related]
9. Biogenic nanoparticles as immunomodulator for tumor treatment.
Cheng K; Kang Q; Zhao X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Nov; 12(6):e1646. PubMed ID: 32464709
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine approaches to improve cancer immunotherapy.
Qiu H; Min Y; Rodgers Z; Zhang L; Wang AZ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28296286
[TBL] [Abstract][Full Text] [Related]
11. Advanced nanotechnology: An arsenal to enhance immunotherapy in fighting cancer.
Cheng CT; Castro G; Liu CH; Lau P
Clin Chim Acta; 2019 May; 492():12-19. PubMed ID: 30711524
[TBL] [Abstract][Full Text] [Related]
12. Gold nanoparticle mediated cancer immunotherapy.
Almeida JP; Figueroa ER; Drezek RA
Nanomedicine; 2014 Apr; 10(3):503-14. PubMed ID: 24103304
[TBL] [Abstract][Full Text] [Related]
13. Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response.
Rawding PA; Bu J; Wang J; Kim DW; Drelich AJ; Kim Y; Hong S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1752. PubMed ID: 34414690
[TBL] [Abstract][Full Text] [Related]
14. Advances in engineering local drug delivery systems for cancer immunotherapy.
Abdou P; Wang Z; Chen Q; Chan A; Zhou DR; Gunadhi V; Gu Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1632. PubMed ID: 32255276
[TBL] [Abstract][Full Text] [Related]
15. Instigation of the epoch of nanovaccines in cancer immunotherapy.
Shah S; Famta P; Tiwari V; Kotha AK; Kashikar R; Chougule MB; Chung YH; Steinmetz NF; Uddin M; Singh SB; Srivastava S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1870. PubMed ID: 36410742
[TBL] [Abstract][Full Text] [Related]
16. Optimizing Advances in Nanoparticle Delivery for Cancer Immunotherapy.
Caster JM; Callaghan C; Seyedin SN; Henderson K; Sun B; Wang AZ
Adv Drug Deliv Rev; 2019 Apr; 144():3-15. PubMed ID: 31330165
[TBL] [Abstract][Full Text] [Related]
17. Advances of functional nanomaterials for cancer immunotherapeutic applications.
Hao Y; Zhou X; Li R; Song Z; Min Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1574. PubMed ID: 31566896
[TBL] [Abstract][Full Text] [Related]
18. Combining nanomedicine and immune checkpoint therapy for cancer immunotherapy.
Boone CE; Wang L; Gautam A; Newton IG; Steinmetz NF
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Jan; 14(1):e1739. PubMed ID: 34296535
[TBL] [Abstract][Full Text] [Related]
19. Improved cancer immunotherapy strategies by nanomedicine.
Guo S; Feng J; Li Z; Yang S; Qiu X; Xu Y; Shen Z
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(3):e1873. PubMed ID: 36576112
[TBL] [Abstract][Full Text] [Related]
20. Engineering nanoparticles to reprogram radiotherapy and immunotherapy: recent advances and future challenges.
Jin J; Zhao Q
J Nanobiotechnology; 2020 May; 18(1):75. PubMed ID: 32408880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
